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Introduction
Genetics is suggested to play role in the development of
Behçet’s disease (BD). Shared phenotipic features requires
an approach to differential diagnosis from periodic febrile
syndromes.
Objectives
We planned to study for mevalonate kinase (MVK) as a
candidate for a susceptibility gene for Behçet’s disease.
Methods
Consecutive Behçet patients and apperently healthy sub-
jects were included. Severity score of Behçet disease was
calculated. Genotyping of mevalonate kinase gene was
done by polymerase chain reaction /sequence-based typing
technique.
Results
50 BD patients (median age: 38.30±11.06 years) and
51 controls (median age: 33.88±12.47 years) were
recruited. Three types of mutations have found. First: A
single nucleotide polymorphism (SNP) c.769-38C>T
(rs35191208) in 21 of 50 BD patients and in 15 of 51 con-
trols. Both groups were comparable for the frequency of
c.769-38C>T (p>0,05). In all of the cases with c.769-
38C>T, a second SNP: c885+24G>A(rs2270374) was also
present (previously reported to be in linkage disequili-
brium with the first SNP). Third SNP: c.769-7T>G
(rs104895331) was found in 3 of 50 BD patients and in
1 of the control group. We found this SNP together with
c769-38C>T and c.885+24G>A. The neurological involve-
ment was found to be more frequent in the BD patients
with c.769-38 C>T when compared to the BD patients
without this polymorphism (p:0,012).
Conclusion
Our results suggested that the effects of MVK mutations
in Behçet’s disease could be an additional genetic suscept-
ibility factor for the patients with neurological involve-
ment. However these results need confirmation in larger
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